That's what I would like to bring across more than anything. I am not a professional trader/investor. I am not even remotely wealthy. I can not make you rich. I have made some money in short term trading and I have lost some money doing the same. Short term trading has been a wash for me as any profits taken were quickly usurped by idiotic losses.
Why? Because I rushed in to trading in companies that I knew next to nothing about. Maybe I saw a newsletter. Maybe a friend mentioned something. However it happened, in retrospect, it was the wrong reason to invest. It sure felt good when a trade was a winner, but I'd take those profits and either try and chase, or would invest in a stinker immediately afterwards.
Through it all though, I have maintained several stocks that I was long out of the gate on, because I saw potential when I studied the companies. These were companies that I saw as having massive upside with minimal risk. Consequently, I invested more in these longs than I ever risked on the short term plays.
These are the stocks that I would like to write about, as I feel they are worth my time to write about.
Everything I write is, of course, my opinion, and in no way should be taken as investment advice.
I am going to write and I don't care if you read it.
I am a keen investor in small cap biotech and exploration companies having made my initial money on a dot.com venture in the Middle East (www.ameinfo.com) and now living in Cyprus.
I have been an angel investor in several start ups some of which are now making their ways up the ladder and I am actively involved as a board member and advisor to several of these companies as well as being a keen researcher into small caps from the biotech and oil exploration and mining sector.
I am Danish with a good sense of humour and a keen sense of curiosity of finding the next big
winner "out there" and I enjoy it !
My formal education ended with a Ph.D. in Biochemistry, minor in Organic Chemistry. After roughly two decades in academic research, my real-world education has continued at two biotech-related companies.
Individual investor with particular interest in any company that is on the cusp of change--for the better. These companies will have at least several attributes in common: They are underfollowed; underappreciated; have a clear, stated strategy for driving profits; management and BOD are perfectly aligned with common shareholders; management team and BOD with a track record of rewarding shareholders; and have near-term catalysts that will have meaningful impact on the business. Simple, right?
Individual investor, part-time, about 20 hours a week. Medical and research background has been helpful in my area of interest which is highly speculative biotechs - device, drugs, and drug delivery platforms.
I am an investor who has a passion for discovering and investing in the compelling and breakthrough companies of our time. I share my humble (and often times not so humble) opinions to help others to ask their own questions as they conduct their own due diligence.
Disclaimer: Articles provide opinions and information, but do not contain recommendations or personal investment advice to any specific person for any particular purpose. Do your own research and/or obtain suitable personal advice from an investment professional.
Retired sales rep I am married with two married children a son and a daughter and two grandchildren. Since I have retired I have invested in biotech and enjoy the challenge of picking winners. I have picked some losers but have learned from my mistakes. Right now I am excited about CTIX and CUR.
My investment thesis is that Cancer will be cured in this decade and the
Magnificent Seven will move us toward the goal CTIX NWBO PCYC THLD SNTA IMUC SBFM
The next Wave will be Regenerative Medicine and a group of biotechs I call the
Cell Biology Seven will lead that wave. ISCO is now the leader of that group and
may become the dominant supplier to others in the field in the same manner that
MSFT came to dominate computer operating systems in prior decades.
The other six are BTX MEDS NNVC BCLI ARWR SRPT